CD34 + cell yield among healthy donors: Large‐scale model development and validation
Journal of Clinical Apheresis · 2024-06 · 39 (3)
DOI: 10.1002/jca.22135 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Journal of Clinical Apheresis, online erschienen am 26.06.2024. Verfasst von Abdullah Alswied und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transfusion Medicine, National Institutes of Health (NIH) Clinical Center, NIH, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Antigens, CD34. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Intramural NIH HHS.
Abstract (Originalsprache)
Background
Successful engraftment in hematopoietic stem cell transplantation necessitates the collection of an adequate dose of CD34+ cells. Thus, the precise estimation of CD34+ cells harvested via apheresis is critical. Current CD34+ cell yield prediction models have limited reproducibility. This study aims to develop a more reliable and universally applicable model by utilizing a large dataset, enhancing yield predictions, optimizing the collection process, and improving clinical outcomes. Materials and Methods A secondary analysis was conducted using the Center for International Blood and Marrow Transplant Research database, involving data from over 17 000 healthy donors who underwent filgrastim‐mobilized hematopoietic progenitor cell apheresis. Linear regression, gradient boosting regressor, and logistic regression classification models were employed to predict CD34+ cell yield.
Results
Key predictors identified include pre‐apheresis CD34+ cell count, weight, age, sex, and blood volume processed. The linear regression model achieved a coefficient of determination ( R 2 ) value of 0.66 and a correlation coefficient ( r ) of 0.81. The gradient boosting regressor model demonstrated marginally improved results with an R 2 value of 0.67 and an r value of 0.82. The logistic regression classification model achieved a predictive accuracy of 96% at the 200 × 10 6 CD34+ cell count threshold. At thresholds of 400, 600, 800, and 1000 × 10 6 CD34+ cell count, the accuracies were 88%, 83%, 83%, and 88%, respectively. The model demonstrated a high area under the receiver operator curve scores ranging from 0.90 to 0.93.
Conclusion
This study introduces advanced predictive models for estimating CD34+ cell yield, with the logistic regression classification model demonstrating remarkable accuracy and practical utility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Transfusion Medicine, National Institutes of Health (NIH) Clinical Center, NIH, Bethesda, Maryland, USA.
- Department of Pharmaceutical Sciences, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
- King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
ORCID-Profile: Abdullah Alswied
Förderung
- Intramural NIH HHS
Zitieren
APA
Alswied, A., Daniel, D., Chen, L. N., Alqahtani, T., & West-Mitchell, K. A. (2024). CD34 + cell yield among healthy donors: Large‐scale model development and validation. Journal of Clinical Apheresis, 39(3). https://doi.org/10.1002/jca.22135
Vancouver
Alswied A, Daniel D, Chen LN, Alqahtani T, West-Mitchell KA. CD34 + cell yield among healthy donors: Large‐scale model development and validation. Journal of Clinical Apheresis. 2024;39(3). doi:10.1002/jca.22135
BibTeX
@article{Alswied2024,
author = {Alswied, Abdullah and Daniel, David and Chen, Leonard N and Alqahtani, Tariq and West-Mitchell, Kamille Aisha},
title = {CD34 + cell yield among healthy donors: Large‐scale model development and validation},
journal = {Journal of Clinical Apheresis},
year = {2024},
volume = {39},
number = {3},
doi = {10.1002/jca.22135}
}
EUVIMED